Company

Septerna

https://septerna.com/

Industrybiotechnology company discovering and advancing novel oral small molecule medicines targeting G protein-coupled receptors (GPCRs)

Funding raised

CompanyRoundDate
SepternaSeries B Financing2023-07-17